首页> 外国专利> OPHTHALMIC COMPOSITIONS OF CARBONIC ANHYDRASE INHIBITORS FOR TOPICAL APPLICATION IN THE TREATMENT OF ELEVATED INTRAOCULAR PRESSURE

OPHTHALMIC COMPOSITIONS OF CARBONIC ANHYDRASE INHIBITORS FOR TOPICAL APPLICATION IN THE TREATMENT OF ELEVATED INTRAOCULAR PRESSURE

机译:碳酸酐酶抑制剂的眼科药物组合物在眼内压升高治疗中的典型应用

摘要

Although dibasic carbonic anhydrase inhibitors (C.A.I.) can be administered systemically by oral or intravenous routes, attempts to administer them topically were inadvisable because of their elevated pH. The mono-alkali metal salts in the treatment of intraocular hypertension especially the sodium and potassium salts, of dibasic salt-forming C.A.I. are as effective in lowering intraocular pressure as dialkali metal salts of dibasic C.A.I. while having a pH more in harmony with ocular pH. They are found particularly useful when administered in conjunction with an ophthalmologically acceptable water-soluble polymer such as hydroxypropylcellulose in an aqueous carrier.
机译:尽管二元碳酸酐酶抑制剂(C.A.I.)可以通过口服或静脉内途径全身性给药,但由于其pH值升高,不建议尝试局部给药。用于治疗眼内高压的单碱金属盐,特别是形成二元盐的C.A.I.的钠盐和钾盐。与二元C.A.I.的二碱金属盐一样,在降低眼内压方面同样有效。 pH值与眼睛pH值更加协调。当与眼科上可接受的水溶性聚合物如羟丙基纤维素一起在水性载体中给药时,发现它们特别有用。

著录项

  • 公开/公告号DE3167999D1

    专利类型

  • 公开/公告日1985-02-14

    原文格式PDF

  • 申请/专利权人 MERCK & CO. INC.;

    申请/专利号DE19813167999T

  • 发明设计人 SMITH ROBERT L.;

    申请日1981-03-03

  • 分类号A61K9/06;

  • 国家 DE

  • 入库时间 2022-08-22 07:58:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号